Midazolam Hydrochloride Injection shortage
Current 27 presentations · 6 manufacturers · first FDA posting 2020-04-02 · last update 2026-10-15
Manufacturers: Avet Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Gland Pharma Limited, Hikma Pharmaceuticals USA, Inc., Hospira, Inc., a Pfizer Company, WG Critical Care
Stated reasons (per FDA): Delay in shipping of the drug; Demand increase for the drug; Other
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) | Avet Pharmaceuticals, Inc. | Current Available |
— | Posted 04/02/2020 Updated 10/15/2026 | |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) | Avet Pharmaceuticals, Inc. | Current Available |
— | Posted 04/02/2020 Updated 10/15/2026 | |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) | Avet Pharmaceuticals, Inc. | Current Available |
— | Posted 04/02/2020 Updated 10/15/2026 | |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Delay in shipping of the drug | Estimated recovery: TBD | Posted 04/02/2020 Updated 10/15/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 04/02/2020 Updated 10/15/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 04/02/2020 Updated 10/15/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) | Fresenius Kabi USA, LLC | Current Available |
— | Check wholesalers for inventory | Posted 04/02/2020 Updated 10/15/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Estimated recovery: TBD | Posted 04/02/2020 Updated 10/15/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Next release October 2026. Check wholesalers for inventory. | Posted 04/02/2020 Updated 10/06/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) | Fresenius Kabi USA, LLC | Current Unavailable |
Demand increase for the drug | Next release November 2026. Check wholesalers for inventory. | Posted 04/02/2020 Updated 10/15/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02) | Gland Pharma Limited | Current Unavailable |
Other | Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals | Posted 04/02/2020 Updated 07/22/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10) | Gland Pharma Limited | Current Unavailable |
Other | Estimated recovery: TBD; Distributed by Sagent Pharmaceuticals | Posted 04/02/2020 Updated 07/22/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Posted 04/02/2020 Updated 10/14/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Posted 04/02/2020 Updated 10/14/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Posted 04/02/2020 Updated 10/14/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Posted 04/02/2020 Updated 10/14/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) | Hikma Pharmaceuticals USA, Inc. | Current Available |
— | Additional lots are scheduled to be manufactured. Product will be made available as it is released. | Posted 04/02/2020 Updated 10/14/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Demand increase for the drug | Limited Supply Available. Next Delivery and Estimated Recovery: December 2026 | Posted 04/02/2020 Updated 10/08/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Demand increase for the drug | Limited Supply Available. Next Delivery: October 2026; Estimated Recovery: December 2026 | Posted 04/02/2020 Updated 10/08/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) | Hospira, Inc., a Pfizer Company | Current Limited Availability |
Demand increase for the drug | Next Estimated Delivery and Estimated Recovery: December 2026 | Posted 04/02/2020 Updated 10/08/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Demand increase for the drug | Next Delivery and Estimated Recovery: December 2026 | Posted 04/02/2020 Updated 10/08/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Demand increase for the drug | Next Delivery: October 2026; Estimated Recovery: December 2026 | Posted 04/02/2020 Updated 10/08/2026 |
| Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) | Hospira, Inc., a Pfizer Company | Current Unavailable |
Demand increase for the drug | Next Delivery: January 2027; Estimated Recovery: March 2027 | Posted 04/02/2020 Updated 10/08/2026 |
| Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 04/02/2020 Updated 10/08/2026 | |
| Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) | Hospira, Inc., a Pfizer Company | Current Available |
— | Posted 04/02/2020 Updated 10/08/2026 | |
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) | WG Critical Care | Current Available |
— | Please check wholesalers and distributors for inventory. | Posted 04/02/2020 Updated 10/01/2026 |
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) | WG Critical Care | Current Available |
— | Please check wholesalers and distributors for inventory. | Posted 04/02/2020 Updated 10/01/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)